Literature DB >> 15331732

Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.

Paul L Boyer1, Tomozumi Imamichi, Stefan G Sarafianos, Edward Arnold, Stephen H Hughes.   

Abstract

Long-term use of combination therapy against human immunodeficiency virus type (HIV-1) provides strong selective pressure on the virus, and HIV-1 variants that are resistant to multiple inhibitors have been isolated. HIV-1 variants containing amino acid substitutions within the coding region of HIV-1 reverse transcriptase (RT), such as the 3'-azido-3'-deoxythymidine (AZT)-resistant variant AZT-R (M41L/D67N/K70R/T215Y/K219Q) and a variant containing an insertion in the fingers domain (S69SGR70/T215Y), are resistant to the nucleoside RT inhibitor (NRTI) AZT because of an increase in the level of excision of AZT monophosphate (AZTMP) from the primer. While rare, variants have also been isolated which contain deletions in the RT coding region. One such virus, described by Imamichi et al. (J. Virol 74:10958-10964, 2000; J. Virol. 74:1023-1028, 2000; J. Virol. 75:3988-3992, 2001), contains numerous amino acid substitutions and a deletion of codon 67, which we have designated the Delta67 complex of mutations. We have expressed and purified HIV-1 RT containing these mutations. We compared the polymerase and pyrophosphorolysis (excision) activity of an RT with the Delta67 complex of mutations to wild-type RT and the two other AZT-resistant variants described above. All of the AZT-resistant variants we tested excise AZTMP and 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA [tenofovir]) from the end of a primer more efficiently than wild-type RT. Although the variant RTs excised d4TMP less efficiently than AZTMP and PMPA, they were able to excise d4TMP more efficiently than wild-type RT. HIV-1 RT containing the Delta67 complex of mutations was not able to excise as broad a range of NRTIs as the fingers insertion variant SSGR/T215Y, but it was able to polymerize efficiently with low concentrations of deoxynucleoside triphosphates and seems to be able to excise AZTMP and PMPA at lower ATP concentrations than AZT-R or SSGR/T215Y, suggesting that a virus containing the Delta67 complex of mutations would replicate reasonably well in quiescent cells, even in the presence of AZT. Copyright 2004 American Society for Microbiology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331732      PMCID: PMC515022          DOI: 10.1128/JVI.78.18.9987-9997.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Case report of a novel amino acid deletion in codon 67 and T69G substitution in the reverse transcriptase of HIV-1.

Authors:  J Giri; H J Rueda; A Monticelli; N Planes
Journal:  Antivir Ther       Date:  2000-09

2.  Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine.

Authors:  J Lennerstrand; D K Stammers; B A Larder
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

3.  [Infrequent deletion in 67 codon in HIV reverse transcriptase in antiretroviral treatment failure].

Authors:  J Giri; H Jáuregui Rueda; A Monticelli; D A Pirola; N Planes
Journal:  Medicina (B Aires)       Date:  2001       Impact factor: 0.653

4.  High-level resistance to 3'-azido-3'-deoxythimidine due to a deletion in the reverse transcriptase gene of human immunodeficiency virus type 1.

Authors:  T Imamichi; T Sinha; H Imamichi; Y M Zhang; J A Metcalf; J Falloon; H C Lane
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase.

Authors:  P L Boyer; S G Sarafianos; E Arnold; S H Hughes
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  Amino acid deletion at codon 67 and Thr-to-Gly change at codon 69 of human immunodeficiency virus type 1 reverse transcriptase confer novel drug resistance profiles.

Authors:  T Imamichi; M A Murphy; H Imamichi; H C Lane
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

7.  Deletions in the beta3-beta4 hairpin loop of HIV-1 reverse transcriptase are observed in HIV-1 isolated from subjects during long-term antiretroviral therapy.

Authors:  L Ross; M Johnson; R G Ferris; S A Short; L R Boone; T E Melby; R Lanier; M Shaefer; M St Clair
Journal:  J Hum Virol       Date:  2000 May-Jun

8.  Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance.

Authors:  A Mas; M Parera; C Briones; V Soriano; M A Martínez; E Domingo; L Menéndez-Arias
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

9.  Relative replication fitness of a high-level 3'-azido-3'-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr-->Gly) at codon 69.

Authors:  T Imamichi; S C Berg; H Imamichi; J C Lopez; J A Metcalf; J Falloon; H C Lane
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

10.  Anti-HIV type 1 activity of 3'-fluoro-3'-deoxythymidine for several different multidrug-resistant mutants.

Authors:  E Y Kim; L Vrang; B Oberg; T C Merigan
Journal:  AIDS Res Hum Retroviruses       Date:  2001-03-20       Impact factor: 2.205

View more
  17 in total

1.  Understanding the molecular mechanism of sequence dependent tenofovir removal by HIV-1 reverse transcriptase: differences in primer binding site versus polypurine tract.

Authors:  Pinar Iyidogan; Karen S Anderson
Journal:  Antiviral Res       Date:  2012-06-01       Impact factor: 5.970

Review 2.  Insertions in the human immunodeficiency virus type 1 protease and reverse transcriptase genes: clinical impact and molecular mechanisms.

Authors:  Mark A Winters; Thomas C Merigan
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

3.  In vitro fidelity of the prototype primate foamy virus (PFV) RT compared to HIV-1 RT.

Authors:  Paul L Boyer; Carolyn R Stenbak; David Hoberman; Maxine L Linial; Stephen H Hughes
Journal:  Virology       Date:  2007-07-12       Impact factor: 3.616

4.  Selection and characterization of HIV-1 with a novel S68 deletion in reverse transcriptase.

Authors:  Raymond F Schinazi; Ivana Massud; Kimberly L Rapp; Meta Cristiano; Mervi A Detorio; Richard A Stanton; Matthew A Bennett; Monique Kierlin-Duncan; Johan Lennerstrand; James H Nettles
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

Review 5.  Recent findings on the mechanisms involved in tenofovir resistance.

Authors:  Pinar Iyidogan; Karen S Anderson
Journal:  Antivir Chem Chemother       Date:  2014-12-16

6.  Structural basis of HIV-1 resistance to AZT by excision.

Authors:  Xiongying Tu; Kalyan Das; Qianwei Han; Joseph D Bauman; Arthur D Clark; Xiaorong Hou; Yulia V Frenkel; Barbara L Gaffney; Roger A Jones; Paul L Boyer; Stephen H Hughes; Stefan G Sarafianos; Eddy Arnold
Journal:  Nat Struct Mol Biol       Date:  2010-09-19       Impact factor: 15.369

7.  Thymidine analogue excision and discrimination modulated by mutational complexes including single amino acid deletions of Asp-67 or Thr-69 in HIV-1 reverse transcriptase.

Authors:  Mónica Kisic; Tania Matamoros; María Nevot; Jesús Mendieta; Javier Martinez-Picado; Miguel A Martínez; Luis Menéndez-Arias
Journal:  J Biol Chem       Date:  2011-04-19       Impact factor: 5.157

8.  HIV-1 reverse transcriptase connection subdomain mutations reduce template RNA degradation and enhance AZT excision.

Authors:  Krista A Delviks-Frankenberry; Galina N Nikolenko; Paul L Boyer; Stephen H Hughes; John M Coffin; Abhay Jere; Vinay K Pathak
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-30       Impact factor: 11.205

Review 9.  HIV-1 reverse transcriptase and antiviral drug resistance. Part 2.

Authors:  Kalyan Das; Eddy Arnold
Journal:  Curr Opin Virol       Date:  2013-04-19       Impact factor: 7.090

10.  Effects of the translocation status of human immunodeficiency virus type 1 reverse transcriptase on the efficiency of excision of tenofovir.

Authors:  Bruno Marchand; Kirsten L White; John K Ly; Nicolas A Margot; Ruth Wang; Martin McDermott; Michael D Miller; Matthias Götte
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.